Digital PCR & Real-Time PCR Market by Type (dPCR, qPCR), Product Type (Instruments, Reagents & Consumables, Services), Application, End-User - Global Forecast 2024-2030

Digital PCR & Real-Time PCR Market by Type (dPCR, qPCR), Product Type (Instruments, Reagents & Consumables, Services), Application, End-User - Global Forecast 2024-2030

The Digital PCR & Real-Time PCR Market size was estimated at USD 8.24 billion in 2023 and expected to reach USD 8.87 billion in 2024, at a CAGR 7.98% to reach USD 14.11 billion by 2030.

Digital PCR (dPCR) and real-time PCR, often referred to as quantitative PCR (qPCR), are two pivotal techniques bodied under the broader field of polymerase chain reaction (PCR) science. Digital PCR (dPCR) is an advanced molecular biology technique for the absolute quantification of nucleic acids, which includes subdividing the sample into many individual, smaller reactions that contain either zero or one template molecule. Real-Time PCR, known as quantitative PCR (qPCR), differs from standard PCR by enabling the detection of the accumulation of amplification product reaction as it occurs in real-time. These techniques are in high demand owing to their heightened precision and sensitivity for detecting low-level pathogens and rare genetic sequences. The surge in the need for early and precise diagnosis and an uptick in genetic disorders and infectious diseases has led to the growth of the digital PCR & real-time PCR market. Further, the COVID-19 pandemic particularly highlighted the critical role of PCR-based diagnostics in managing infectious outbreaks. Despite its growth, the digital PCR & real-time PCR market contend with limitations, including the variability in the size and shape of droplets, which affect the robustness of the method and the need for specialized expertise in developing economies. However, growing investments by industry participants in R&D and the emergence of droplet digital PCR (ddPCR) technology for exquisite precision and sensitivity promise future prospects for the digital PCR & real-time PCR market growth.

Regional Insights

In the Americas, the digital PCR & real-time PCR market is showing robust growth, attributed to the region's strong biotechnology and pharmaceutical sectors, active government investments in healthcare research, and the wide adoption of technologically advanced diagnostic methods. The European market for digital PCR & real-time PCR is witnessing steady growth owing to the need for advanced capabilities to counter the increasing prevalence of infectious diseases, genetic disorders, and various types of cancer. Advanced healthcare infrastructure and significant investments in R&D activities in the biotechnology sector underpin the market expansion in the region. The growth in the Middle East and Africa is propelled by improving healthcare facilities, economic development, and increased access to innovative diagnostic technologies. The Asia-Pacific is emerging as the fastest-growing regional market for dPCR and qPCR technologies. The growth is largely fueled by the expanding biomedical industry in countries such as China, Japan, India, South Korea, and Australia. The region's large population base presents a significant demand for advanced diagnostic methods including dPCR and qPCR. Increased government expenditure on healthcare and the rising prevalence of chronic diseases are further catalyzing the market growth in the region.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Digital PCR & Real-Time PCR Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Benefits of dPCR & qPCR for clinical virology diagnostics
Increasing incidences of genetic and infectious diseases
Applications of dPCR & qPCR in authenticate plant-derived products

Market Restraints

Stringent regulatory guidelines regarding dPCR & qPCR techniques

Market Opportunities

Emergence of droplet digital PCR (ddPCR) technology
Emerging applications of dPCR & qPCR in biomarker discovery

Market Challenges

Limitations associated with dPCR & qPCR techniques

Market Segmentation Analysis

Type: Higher preferences for qPCR for high throughput and a broader dynamic range
Product Type: Growing demand for application-specific kits that address the needs of specialized end-users
Application: Higher potential in forensics for paternity testing and the detection of low-level DNA in crime scene investigations
End-User: Significant applications of dPCR & qPCR in the personalized drug development he

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Digital PCR & Real-Time PCR Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Digital PCR & Real-Time PCR Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Roche Launches Next-Generation qPCR System to Advance Clinical Needs in Molecular Diagnostics and Address Public Health Challenges

F. Hoffmann-La Roche Ltd. has introduced the LightCycler PRO qPCR system, which deliver agility and flexibility for translational research and in vitro diagnostics. This system offers the users an opportunity to develop their own tests and access a wide range of LightMix Modular research assays and LightMix CE-IVD assays from TIB Molbiol, a subsidiary of Roche.

QIAGEN Launches New QIAcuity Digital PCR Kits and Updated Software to Expand Use by Biopharma and Food Safety Customers

QIAGEN N.V. has introduced three new kits along with a new software update for its QIAcuity systems to enhance digital PCR applications in biopharma research and food safety. The QIAcuity Mycoplasma Quant Kit allows researchers to accurately and precisely detect mycoplasma contaminants, complying with testing frameworks from the US, EU, and Japanese Pharmacopeia. The updated software aims to facilitate digital PCR technology in various areas, including cell and gene therapies, DNA/RNA quantification, food safety, and pharmaceuticals safety.

Seegene and Werfen Partner on Syndromic qPCR Assays Development

Seegene, Inc., a South Korean diagnostic company, has partnered with Werfen, S.A to develop syndromic qPCR assays specifically designed for the Spanish and Portuguese healthcare markets. Werfen to develop these assays under Seegene's OneSystem business.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Digital PCR & Real-Time PCR Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Digital PCR & Real-Time PCR Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Inc., Agilent Technologies, Inc., Analytik Jena GmbH+Co. KG, Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocompare by CompareNetworks, Inc., BIOMÉRIEUX S.A., Bioneer Corporation, Danaher Corporation, ELITech Group, Enzo Life Sciences, Inc., Eppendorf SE, Etcon Analytical and Environmental Systems & Services Ltd., Explorea s.r.o, F. Hoffmann-La Roche AG, Global Engage Sdn. Bhd., Hangzhou Longgene Scientific Instruments Co., Ltd., Heal Force Bio-Meditech Holdings Limited, Integrated DNA Technologies, Inc., LABGENE Scientific SA, Merck KGaA, Meridian Bioscience, Inc., Promega Corporation, QIAGEN N.V., Quidel Corporation, R-Biopharm AG, RainSure Scientific, Roche Diagnostics Corporation, Solis BioDyne OÜ, STANDARD BIOTOOLS INC., Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp.

Market Segmentation & Coverage

This research report categorizes the Digital PCR & Real-Time PCR Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
dPCR
qPCR
Product Type
Instruments
Reagents & Consumables
Services
Application
Clinical Research
Forensic Labs
Research Institutes
End-User
Academic & Research Institutes
Agriculture & Lifescience
CROs & CDMOs
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biopharmaceutical Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year